Skip to content
Recall Observatory FDA recall evidence

Drug product

Olanzapine, Orally Disintegrating Tablets, 5 mg, a) 30-count bottle (NDC 60505-3275-03), b) 100-count blister (NDC 60505-3275-00), Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9

D-1079-2015

April 07, 2015

Class III

Product summary

Firm
Apotex Inc.
Event
Event 71046
Status
Terminated
Classification
Class III
Quantity
23,274 bottles/ blister cartons
Official record key
drug-enforcement:D-1079-2015

Official wording

Reason: Subpotent drug

Code information: Lot #: a) KL0655, Exp 04/15; KY2374, Exp 05/16; b) KL0656, Exp 04/15; KY2371, Exp 05/16

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent